We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.23B
AUM Growth
+$298M
(+4.3%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
2.07%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
1,100
New
151
Increased
415
Reduced
333
Closed
164
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$40.6M |
| 2 |
Autodesk
ADSK
|
+$38.8M |
| 3 |
Intuit
INTU
|
+$37.1M |
| 4 |
Ecolab
ECL
|
+$35.6M |
| 5 |
Coca-Cola
KO
|
+$35.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$51.9M |
| 2 |
EOG Resources
EOG
|
+$33.8M |
| 3 |
DATA
Tableau Software, Inc.
DATA
|
+$32M |
| 4 |
Microsoft
MSFT
|
+$29.8M |
| 5 |
Ford
F
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 17.68% |
| 3 | Consumer Discretionary | 13.74% |
| 4 | Industrials | 11.53% |
| 5 | Healthcare | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Valvoline
VVV
$4.97B
| $18.9M | 0.26% |
966,918
+795,348
| +464% | +$14.7M |
|
102
General Motors
GM
$74.7B
| $18.9M | 0.26% |
489,429
+165,960
| +51% | +$6.22M |
|
|
ZNGA
103
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $18.2M | 0.25% |
2,975,921
-1,120,983
| -27% | -$6.61M |
|
|
TECD
104
DELISTED
Tech Data Corp
TECD
| $18.1M | 0.25% |
172,656
-16,380
| -9% | -$1.66M |
|
105
American Express
AXP
$223B
| $17.8M | 0.25% |
144,420
+108,870
| +306% | +$12.8M |
|
106
Avnet
AVT
$7.33B
| $17.7M | 0.24% |
390,185
+24,760
| +7% | +$1.11M |
|
107
Madison Square Garden
MSGS
$9.54B
| $17.7M | 0.24% |
88,435
+13,563
| +18% | +$2.89M |
|
108
Cullen/Frost Bankers
CFR
$10.3B
| $17.2M | 0.24% |
183,154
-19,920
| -10% | -$1.95M |
|
109
Workiva
WK
$2.94B
| $17.1M | 0.24% |
293,759
+12,162
| +4% | +$652K |
|
|
MDRX
110
DELISTED
Veradigm Inc. Common Stock
MDRX
| $17M | 0.24% |
1,462,549
+26,810
| +2% | +$273K |
|
111
Incyte
INCY
$23.5B
| $16.9M | 0.23% |
198,447
-100,233
| -34% | -$8.04M |
|
112
CBRE Group
CBRE
$40.8B
| $16.7M | 0.23% |
326,242
-234,859
| -42% | -$11.7M |
|
113
Celanese
CE
$5.09B
| $16.7M | 0.23% |
155,144
+144,104
| +1,305% | +$14.9M |
|
114
Green Dot
GDOT
$753M
| $16.6M | 0.23% |
339,726
+148,609
| +78% | +$8.09M |
|
115
Textron
TXT
$16.6B
| $16.3M | 0.22% |
306,395
-49,770
| -14% | -$2.52M |
|
116
Electronic Arts
EA
$52.4B
| $16.2M | 0.22% |
159,537
+59,986
| +60% | +$5.71M |
|
117
Hartford Financial Services
HIG
$38.5B
| $16.1M | 0.22% |
288,629
-5,260
| -2% | -$278K |
|
118
ResMed
RMD
$28.3B
| $15.9M | 0.22% |
+130,650
| New | +$14.5M |
|
119
Amgen
AMGN
$203B
| $15.5M | 0.21% |
+84,190
| New | +$15.1M |
|
120
Commault Systems
CVLT
$5.89B
| $15.5M | 0.21% |
311,487
+30,900
| +11% | +$1.64M |
|
121
Cogent Communications
CCOI
$594M
| $15.1M | 0.21% |
255,208
+44,940
| +21% | +$2.58M |
|
122
Nexstar Media Group
NXST
$5.6B
| $15M | 0.21% |
148,059
+32,950
| +29% | +$3.54M |
|
123
Take-Two Interactive
TTWO
$43B
| $14.9M | 0.21% |
131,290
+53,340
| +68% | +$5.49M |
|
124
Citizens Financial Group
CFG
$30.4B
| $14.9M | 0.21% |
420,605
-238,221
| -36% | -$8.3M |
|
125
Eastman Chemical
EMN
$7.8B
| $14.7M | 0.2% |
189,258
+65,741
| +53% | +$4.99M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2019 Portfolio in Review
As of Q2 2019, Jacobs Levy Equity Management held 1,100 positions worth $7.23B, up 4.3% from $6.93B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jacobs Levy Equity Management's Q2 2019 filing shows 151 new, 415 increased, 333 reduced and 164 closed positions. Its largest new stake was Biogen: 175,817 shares worth $41.1M. The largest sale was Allergan plc, an estimated $51.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2019 buy was Biogen: 175,817 shares worth $41.1M.
- Jacobs Levy Equity Management added most to Ecolab in Q2 2019, an estimated $35.6M increase.
- Jacobs Levy Equity Management's biggest Q2 2019 reduction was EOG Resources, cutting an estimated $33.8M.
- Jacobs Levy Equity Management fully exited Allergan plc in Q2 2019, selling an estimated $51.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 15% of its $7.23B portfolio in Q2 2019.
- Jacobs Levy Equity Management opened 151 new positions and closed 164 in Q2 2019.
- Jacobs Levy Equity Management's portfolio value rose 4.3% quarter-over-quarter to $7.23B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2019, filed 13 Aug 2019.